|
|
Blood, 1 April 2004, Vol. 103, No. 7, pp. 2661-2667.
Prepublished online as a Blood First Edition Paper on November 13, 2003; DOI 10.1182/blood-2003-06-2154.
 Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis
Sanjay Tiwari,
Kyriacos Felekkis,
Eun-Yi Moon,
Amanda Flies,
David H. Sherr, and
Adam Lerner
From the Department of Medicine, Section of Hematology and Oncology, Boston Medical Center, Boston, MA; Departments of Pathology and Microbiology, Boston University School of Medicine, Boston, MA; and the Department of Environmental Health, Boston University School of Public Health, Boston, MA.
Type 4 cyclic adenosine monophosphate (cAMP) phosphodiesterase (PDE4) inhibitors and other agents that raise intracellular cAMP levels induce apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) but not in T-CLL or peripheral blood T cells. Two principal effector proteins for cAMP are protein kinase A (PKA) and EPAC (exchange protein directly activated by cAMP), a Rap guanosine 5'-diphosphate (GDP) exchange factor. We here examine whether varying expression of EPAC accounts for the discrepant sensitivity of B-CLL and T cells to PDE4 inhibitor-induced apoptosis. B-CLL and peripheral blood B cells express EPAC1 transcript, whereas T-CLL, peripheral blood T cells, monocytes, and neutrophils do not. Treatment with the PDE4 inhibitor rolipram induces Rap1 activation in B-CLL cells but not in peripheral blood B cells, T-CLL, or any of the normal hematopoietic lineages examined. The EPAC-specific cAMP analog 8CPT-2Me-cAMP (8-(4-chloro-phenylthio)-2'-O-methyladenosine-3',5'-cAMP) activates Rap1 in B-CLL cells, but, unlike rolipram/forskolin or 8-Bromo-cAMP, it does not induce PKA activation, as judged by phosphorylation of the transcription factor cAMP-response element binding protein (CREB). Unexpectedly, whereas rolipram/forskolin and 8-Bromo-cAMP induce apoptosis in B-CLL cells, 8CPT-2Me-cAMP decreased basal apoptosis in B-CLL cells by an average of 25% (P < .002). Our results demonstrate that B-CLL cells uniquely activate Rap1 in response to PDE4 inhibitors and suggest that physiologic stimuli that activate EPAC may transmit an antiapoptotic signal. (Blood. 2004;103:2661-2667)
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. A. Meyers, D. W. Su, and A. Lerner
Chronic Lymphocytic Leukemia and B and T Cells Differ in Their Response to Cyclic Nucleotide Phosphodiesterase Inhibitors
J. Immunol.,
May 1, 2009;
182(9):
5400 - 5411.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Gates, S. Hohenester, M. S. Anwer, and C. R. L. Webster
cAMP-GEF cytoprotection by Src tyrosine kinase activation of phosphoinositide-3-kinase p110 {beta}/{alpha} in rat hepatocytes
Am J Physiol Gastrointest Liver Physiol,
April 1, 2009;
296(4):
G764 - G774.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Zhang, F. Murray, A. Zahno, J. R. Kanter, D. Chou, R. Suda, M. Fenlon, L. Rassenti, H. Cottam, T. J. Kipps, et al.
Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia
PNAS,
December 9, 2008;
105(49):
19532 - 19537.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. J. Till, R. J. Harris, A. Linford, D. G. Spiller, M. Zuzel, and J. C. Cawley
Cell Motility in Chronic Lymphocytic Leukemia: Defective Rap1 and {alpha}L{beta}2 Activation by Chemokine
Cancer Res.,
October 15, 2008;
68(20):
8429 - 8436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. El Zein, B. Badran, and E. Sariban
VIP differentially activates {beta}2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1
J. Leukoc. Biol.,
April 1, 2008;
83(4):
972 - 981.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Zhang, A. C. Zambon, K. Vranizan, K. Pothula, B. R. Conklin, and P. A. Insel
Gene Expression Signatures of cAMP/Protein Kinase A (PKA)-promoted, Mitochondrial-dependent Apoptosis: COMPARATIVE ANALYSIS OF WILD-TYPE AND cAMP-DEATHLESS S49 LYMPHOMA CELLS
J. Biol. Chem.,
February 15, 2008;
283(7):
4304 - 4313.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Meyers, J. Taverna, J. Chaves, A. Makkinje, and A. Lerner
Phosphodiesterase 4 Inhibitors Augment Levels of Glucocorticoid Receptor in B Cell Chronic Lymphocytic Leukemia but Not in Normal Circulating Hematopoietic Cells
Clin. Cancer Res.,
August 15, 2007;
13(16):
4920 - 4927.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Lorenowicz, J. van Gils, M. de Boer, P. L. Hordijk, and M. Fernandez-Borja
Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis
J. Leukoc. Biol.,
December 1, 2006;
80(6):
1542 - 1552.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Seino and T. Shibasaki
PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis
Physiol Rev,
October 1, 2005;
85(4):
1303 - 1342.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Xu, B. Duan, B. P. Croker, E. K. Wakeland, and L. Morel
Genetic Dissection of the Murine Lupus Susceptibility Locus Sle2: Contributions to Increased Peritoneal B-1a Cells and Lupus Nephritis Map to Different Loci
J. Immunol.,
July 15, 2005;
175(2):
936 - 943.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Aronoff, C. Canetti, C. H. Serezani, M. Luo, and M. Peters-Golden
Cutting Edge: Macrophage Inhibition by Cyclic AMP (cAMP): Differential Roles of Protein Kinase A and Exchange Protein Directly Activated by cAMP-1
J. Immunol.,
January 15, 2005;
174(2):
595 - 599.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. G. Smith, F. Wang, K. N. Wilkinson, K. J. Savage, U. Klein, D. S. Neuberg, G. Bollag, M. A. Shipp, and R. C. T. Aguiar
The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma
Blood,
January 1, 2005;
105(1):
308 - 316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
